INMD(InMode Ltd.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $357.56M | $454.27M | $492.05M | $394.82M | $370.50M |
| 毛利润 | $303.97M | $380.79M | $411.34M | $317.07M | $290.97M |
| 营业利润 | $167.48M | $197.85M | $195.66M | $112.53M | $85.39M |
| 净利润 | $164.97M | $161.52M | $197.92M | $181.28M | $93.83M |
| 经营现金流 | $174.88M | $181.58M | $176.83M | $132.66M | $85.26M |
| 自由现金流 | $173.95M | $180.00M | $176.12M | $132.00M | $84.28M |
| 摊薄每股收益 | $1.92 | $1.89 | $2.30 | $2.25 | $1.43 |